The peptide guanylin, which has recently been isolated from the intestine, is involved in the regulation of fluid secretion in the intestinal epithelium by activation of guanylate cyclase C, the putative guanylin receptor. Since the latter protein is also expressed in airway epithelia, we investigated the lung of three mammalian species for the presence and cellular localization of guanylin by immunoblot (Western blot) analyses and light and electron microscopical immunocytochemistry. In Western blots of bovine, guinea pig, and rat lung extracts, three different guanylin antisera directed against the midportion and against the C terminus of the precursor molecule identified a peptide band corresponding to the apparent molecular mass of guanylin. Localization studies in the lung revealed that guanylin is exclusively confined to nonciliated secretory (Clara) cells in the lining of distal conducting airways. The presence of guanylin in the lung and particularly its specific localization to Clara cells indicate that these cells may play a pivotal role in the local (paracrine) regulation of electrolyte/water transport in airway epithelia.
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Guanylin is a 15-amino acid peptide that has recently been isolated from jejunal extracts (1) . This peptide shares partial structural identity with heat-stable enterotoxins produced by pathogenic strains of Escherichia coli that cause secretory diarrhea (1) . Cloning of guanylin cDNA from rat and human intestinal cDNA libraries has determined that guanylin is synthesized as a 115-amino acid precursor, with its C terminus being the peptide isolated from intestinal extracts (2) (3) (4) (5) . The guanylin gene, recently cloned and characterized in our laboratory, consists of three exons interrupted by two introns (6) . In the gastrointestinal tract, we have localized guanylin to enterochromaffin cells (7) . Evidence has accumulated that this peptide is involved in the local regulation of electrolyte/water secretion in intestinal epithelia (8, 9) by activation of guanylate cyclase C (1, 2, 8) , the guanylin receptor that is located on the brush border of enterocytes (10, 11) . The induced elevation of cytosolic cGMP in the latter cells leads to activation of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl-channel (12, 13) with a subsequent secretion of Cl- (14, 15) .
Directional electrolyte/water transport is one of the specific functions of airway epithelia (16, 17) . While dysfunctions in fluid secretion (e.g., cystic fibrosis) in these epithelia have been known for several years, the regulatory mechanisms for electrolyte/water transport in pulmonary epithelia largely remained enigmatic. As is the case in intestinal mucosa (5, 18, 19) , both guanylate cyclase C and the CFTR Cl-channel are expressed in airway epithelia (5, (19) (20) (21) . Hence, it is reasonable to analyze whether guanylin is also present in the lung as a potential local regulator of fluid secretion. Therefore, we
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
have raised antisera against the midportion and against the C terminus of the guanylin precursor molecule and investigated lungs of three mammalian species by immunoblot (Western blot) analyses and immunocytochemistry at both the light and electron microscopical level. Our study demonstrates the presence of guanylin in the mammalian lung, and its specific localization to bronchiolar nonciliated secretory Clara cells, implicating these cells in the local regulation of electrolyte/ water transport in airway epithelia.
MATERIALS AND METHODS
Peptide Synthesis, Immunization Procedure, and Antisera. From the published proguanylin sequence (2-5), the peptides guanylin-(34-46), guanylin-(101-115), and [Lys100]guanylin-(101-115) were synthesized as described (7) . Rabbits (New Zealand White, five for each antigen) were immunized subcutaneously with guanylin-(34-46) and [Lys100]guanylin-(101-115) (7) .
After testing the titer in enzyme-linked immunosorbent assays, three antisera [K42 directed against guanylin-(34-46) and K605 and K606, each directed against guanylin-(101-115)] were used in the present work. K42 and K605 had already been used and characterized (7) .
Extraction of Guanylin from Tissues and Western Blot Procedure. Lung tissues from cattle (n = 2), guinea pig (n = 4), and rat (n = 2) were excised and rinsed extensively in ice-cold saline. Guinea pig duodenum and jejunum served as positive controls, and skeletal muscle and testis from guinea pig and rat were used as negative control tissues. Extraction of guanylin from these tissues and subsequent Western blots including visualization of immunoreactive proteins were performed according to two different protocols: (i) the working protocol as published (7) (wt/vol) dithiothreitol, 2 ,ug each of pepstatin and leupeptin per ml, and 1 mM phenylmethylsulfonyl fluoride served as sample buffer. After centrifugation (12,000 x g at 40C for 15 min), the supernatants were boiled for 4 min. The samples were then separated by tricine-SDS/PAGE (7, 22) (23) . The specimens for immunoelectron microscopy were embedded in Araldite, and those for routine electron microscopy were embedded in Epon.
Immunocytochemical Protocol. Light microscopy. Paraffin sections (4-7 ,um) were immunostained for guanylin (antiserum K42, diluted 1:1000-2000; antisera K605 and K606, each diluted 1:1000-4000) by the avidin-biotin-peroxidase complex (ABC) technique; the incubation sequences and the visualization of the antigen-antibody binding sites were performed as detailed (7) . For investigations at the single-cell level, serial semithin (0.5 ,um) sections were alternatively immunostained with the antisera K42, K605, and K606 by the ABC technique.
Immunoelectron microscopy. Ultrathin sections were immunostained by the antisera K42 and K605 (each diluted 1:1000) by using the immunogold technique as described (7) . Thereafter, the sections were air-dried, counterstained with uranyl acetate for 10 min, rinsed in H20 for 2 min, and investigated in an electron microscope (Zeiss EM 10).
Specificity controls. Method-dependent nonspecificities were excluded by running controls as published (7) . Antibody specificities were tested by preadsorption of each of the guanylin antisera with homologous and heterologous antigens in concentrations of 6.25-100 ,ug per ml of the antiserum (working dilution). Preadsorption of the antiserum K42 with guanylin- (34) (35) (36) (37) (38) (39) (40) (41) (42) (43) (44) (45) (46) (Fig. 3A-C) . By the absence of cilia and by their typical localization they were identified as Clara cells (as also confirmed by immunoelectron microscopy; see below), which are known to predominate in the epithelium of distal conducting airways (24) . Remarkably, the number of guanylin-immunoreactive cells declined in larger airways, and the epithelial lining of proximal cartilaginous airways (trachea, bronchi) lacked any guanylin-immunoreactive cells. Investigations of guanylin immunoreactivity at the single-cell level revealed that all three guanylin antisera immunostained the same cells localized in the epithelium of small bronchioles as demonstrated in serial sections alternatively immunostained by the antisera K42, K605, or K606 (Fig. 3 D and E) . Although these cells contained coarse-grained guanylin immunoreactivities throughout the cytoplasm, the immunoreactivity was concentrated in the apical regions of these cells facing the airway lumen. In the entire airway branching, ciliated cells, endocrine cells (identified by an antiserum against chromogranin A; seẽ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~H A~~~M smt h M .
ref. 7) , subepithelial tissues, alveolar cells, alveolar macrophages, lung mast cells, and endothelial cells of capillaries were completely unreactive toward each of the three guanylin antisera.
At the subcellular level, guanylin immunoreactivity was confined exclusively to nonciliated cells exhibiting ultrastructural features of Clara cells (24, 25) . By routine electron microscopy, these cells were clearly identified in the epithelium of small bronchioles located between the ciliated cells (Fig.  4A) . In agreement with reports in the literature (24, 25) , Clara cells possessed slender microvilli at their luminal surface and were characterized by their content of secretory granules that accumulated in supranuclear regions of these cells (Fig. 4  A-E) . Among the different types of granules identified in these cells (24, 25) , secretory granules of low or moderate electron density with a finely granulated matrix were strongly immunoreactive for guanylin. These granules were usually located underneath the apical plasma membrane of Clara cells (Fig. 4 The Clara cell is a typical secretory cell of small airways that contains abundant endoplasmic reticulum and secretory granules of different types (24, 25) . Clara cells are especially numerous in small bronchioles, but in small animals they also occur in proximal, cartilaginous airways (24 (14) . A cAMP-dependent protein kinase is apparently a major mediator of this effect (14) . Since the action of guanylin is eliminated in transporting epithelia from transgenic cystic fibrosis mice (9) , it seems predictable that the CFTR Cl-channel is the final and one specific effector of the guanylin-signaling pathway (14) . Previous morphological and experimental studies on Clara cells have speculated on a possible connection between these cells and the regulation of fluid balance in small airways (25, 34) . Indeed, the presence of guanylin in the lung where it is confined to Clara cells indicates that this cell type is involved in the local (paracrine) regulation of electrolyte/water secretion in terminal airway epithelia through a luminocrine secretory pathway of guanylin. Hence, pertinent findings are expected from studies focused on the regulation of guanylin biosynthesis in Clara cells, in respective tumors, and particularly in cystic fibrosis.
